Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous vs Perineural Ondansetron in Laparoscopic Sleeve Gastrectomy
NCT06810882Recruiting
- Sponsor
- Tanta University
- Start
- Feb 2025
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ondansetron in postoperative nausea and vomiting (PONV) and postoperative pain (2 arms), sponsored by Tanta University. Primary endpoints: Incidence of vomiting at 8 hours and Degree of postoperative pain at 1 hour. Started Feb 2025; status: recruiting.
02
Drugs
ondansetron
03
Conditions
postoperative nausea and vomiting (PONV)postoperative pain
Beyond the preview
Go deeper on NCT06810882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06810882.